Evidence map›Paper›PMID 38553455›Full record

ArticleNature communications2024

DELVE: feature selection for preserving biological trajectories in single-cell data.

Jolene S Ranek, Wayne Stallaert, J Justin Milner, Margaret Redick, Samuel C Wolff, Adriana S Beltran, Natalie Stanley, Jeremy E Purvis

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Spherical Manifolds Capture Drug-Induced Changes in Tumor Cell Cycle Behavior.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2025
    Article
  12. Article
  13. Leveraging Single-Cell RNA-Seq to Generate Robust Microglia Aging Clocks.bioRxiv : the preprint server for biology · 2024
    Article
  14. Article
  15. Article
  16. Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Jolene S RanekDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Wayne StallaertDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-8064-6503
J Justin MilnerDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-0752-2130
Margaret RedickDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-1901-458X
Samuel C WolffDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Adriana S BeltranDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Natalie StanleyComputational Medicine Program, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. natalies@cs.unc.edu.ORCID http://orcid.org/0009-0006-8686-1638
Jeremy E PurvisDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. purvisj@email.unc.edu.ORCID http://orcid.org/0000-0002-6963-0524

Funding

UG Support Administrative Supplement: Computational Models of the Human Cell Cycle to Reveal Disease Mechanism and Inform TreatmentR01GM138834 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jeremy Purvis · 2020 to 2026
$2.7M
UNC Predoc Training Progr in Bioinformatics/Comp BiologyT32GM067553 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ELSTON, TIMOTHY C · 2005 to 2019
$2.5M
Cell cycle paths as a framework for understanding drug resistance in tumor cell subpopulationsR01CA280482 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jeanette Gowen Cook, Michael James Emanuele · 2024 to 2026
$1.8M
Automating the Discovery of Clinically-Relevant Intracellular Signaling Responses in Immune Cell-TypesR21AI171745 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STANLEY, NATALIE M · 2023 to 2024
$400k
Inferring Gene Regulatory Networks Governing Definitive Endoderm Differentiation from Single Cell RNA Velocity MeasurementsF31HL156433 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RANEK, JOLENE SARAH · 2021 to 2023
$82k
NCI NIH HHS R01 CA280482NHLBI NIH HHS F31 HL156433NIAID NIH HHS R21 AI171745NIGMS NIH HHS R01 GM138834NIGMS NIH HHS T32 GM067553
6 · The paper itself

Abstract

Single-cell technologies can measure the expression of thousands of molecular features in individual cells undergoing dynamic biological processes. While examining cells along a computationally-ordered pseudotime trajectory can reveal how changes in gene or protein expression impact cell fate, identifying such dynamic features is challenging due to the inherent noise in single-cell data. Here, we present DELVE, an unsupervised feature selection method for identifying a representative subset of molecular features which robustly recapitulate cellular trajectories. In contrast to previous work, DELVE uses a bottom-up approach to mitigate the effects of confounding sources of variation, and instead models cell states from dynamic gene or protein modules based on core regulatory complexes. Using simulations, single-cell RNA sequencing, and iterative immunofluorescence imaging data in the context of cell cycle and cellular differentiation, we demonstrate how DELVE selects features that better define cell-types and cell-type transitions. DELVE is available as an open-source python package: https://github.com/jranek/delve .

Indexed as

Gene Expression ProfilingSoftwareCell CycleCell DifferentiationSequence Analysis, RNASingle-Cell Analysis

Identifiers

PMID38553455
PMCPMC10980758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.